IOSP logo

Innospec (IOSP) Cash and cash equivalents

annual cash & cash equivalents:

$289.20M+$85.50M(+41.97%)
December 31, 2024

Summary

  • As of today (June 2, 2025), IOSP annual cash & cash equivalents is $289.20 million, with the most recent change of +$85.50 million (+41.97%) on December 31, 2024.
  • During the last 3 years, IOSP annual cash & cash equivalents has risen by +$147.40 million (+103.95%).
  • IOSP annual cash & cash equivalents is now at all-time high.

Performance

IOSP Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOSPbalance sheet metrics

quarterly cash & cash equivalents:

$299.80M+$10.60M(+3.67%)
March 31, 2025

Summary

  • As of today (June 2, 2025), IOSP quarterly cash & cash equivalents is $299.80 million, with the most recent change of +$10.60 million (+3.67%) on March 31, 2025.
  • Over the past year, IOSP quarterly cash & cash equivalents has increased by +$29.70 million (+11.00%).
  • IOSP quarterly cash & cash equivalents is now -1.32% below its all-time high of $303.80 million, reached on September 30, 2024.

Performance

IOSP quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOSPbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

IOSP Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+42.0%+11.0%
3 y3 years+104.0%+183.9%
5 y5 years+282.0%+340.2%

IOSP Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+104.0%-1.3%+319.9%
5 y5-yearat high+282.0%-1.3%+415.1%
alltimeall timeat high+1980.6%-1.3%+2056.8%

IOSP Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$299.80M(+3.7%)
Dec 2024
$289.20M(+42.0%)
$289.20M(-4.8%)
Sep 2024
-
$303.80M(+26.5%)
Jun 2024
-
$240.20M(-11.1%)
Mar 2024
-
$270.10M(+32.6%)
Dec 2023
$203.70M(+38.5%)
$203.70M(-1.7%)
Sep 2023
-
$207.20M(+24.9%)
Jun 2023
-
$165.90M(+12.5%)
Mar 2023
-
$147.50M(+0.3%)
Dec 2022
$147.10M(+3.7%)
$147.10M(+46.4%)
Sep 2022
-
$100.50M(+40.8%)
Jun 2022
-
$71.40M(-32.4%)
Mar 2022
-
$105.60M(-25.5%)
Dec 2021
$141.80M(+34.7%)
$141.80M(+59.0%)
Sep 2021
-
$89.20M(-5.5%)
Jun 2021
-
$94.40M(-19.3%)
Mar 2021
-
$117.00M(+11.1%)
Dec 2020
$105.30M(+39.1%)
$105.30M(+58.1%)
Sep 2020
-
$66.60M(+14.4%)
Jun 2020
-
$58.20M(-14.5%)
Mar 2020
-
$68.10M(-10.0%)
Dec 2019
$75.70M(-38.5%)
$75.70M(-31.4%)
Sep 2019
-
$110.30M(+4.0%)
Jun 2019
-
$106.10M(-14.1%)
Mar 2019
-
$123.50M(+0.3%)
Dec 2018
$123.10M(+36.5%)
$123.10M(+34.7%)
Sep 2018
-
$91.40M(+38.5%)
Jun 2018
-
$66.00M(-15.5%)
Mar 2018
-
$78.10M(-13.4%)
Dec 2017
$90.20M(-11.5%)
$90.20M(+37.7%)
Sep 2017
-
$65.50M(+34.2%)
Jun 2017
-
$48.80M(+7.5%)
Mar 2017
-
$45.40M(-55.4%)
Dec 2016
$101.90M(-25.6%)
$101.90M(-39.0%)
Sep 2016
-
$167.10M(+9.1%)
Jun 2016
-
$153.20M(+35.1%)
Mar 2016
-
$113.40M(-17.2%)
Dec 2015
$136.90M(+229.1%)
$136.90M(+7.2%)
Sep 2015
-
$127.70M(+98.6%)
Jun 2015
-
$64.30M(+38.3%)
Mar 2015
-
$46.50M(+11.8%)
Dec 2014
$41.60M(-48.1%)
$41.60M(-54.0%)
Sep 2014
-
$90.40M(-1.1%)
Jun 2014
-
$91.40M(+1.4%)
Mar 2014
-
$90.10M(+12.3%)
Dec 2013
$80.20M(+258.0%)
$80.20M(+48.8%)
Sep 2013
-
$53.90M(-1.5%)
Jun 2013
-
$54.70M(+26.6%)
Mar 2013
-
$43.20M(+92.9%)
Dec 2012
$22.40M(-70.6%)
$22.40M(-82.7%)
Sep 2012
-
$129.60M(+22.5%)
Jun 2012
-
$105.80M(+16.0%)
Mar 2012
-
$91.20M(+19.7%)
Dec 2011
$76.20M
$76.20M(-42.3%)
DateAnnualQuarterly
Sep 2011
-
$132.10M(+33.4%)
Jun 2011
-
$99.00M(+10.1%)
Mar 2011
-
$89.90M(-16.1%)
Dec 2010
$107.10M(+56.1%)
$107.10M(+8.4%)
Sep 2010
-
$98.80M(+34.1%)
Jun 2010
-
$73.70M(+14.8%)
Mar 2010
-
$64.20M(-6.4%)
Dec 2009
$68.60M(+393.5%)
$68.60M(+36.7%)
Sep 2009
-
$50.20M(+12.8%)
Jun 2009
-
$44.50M(+25.4%)
Mar 2009
-
$35.50M(+155.4%)
Dec 2008
$13.90M(-42.8%)
$13.90M(-8.6%)
Sep 2008
-
$15.20M(-7.3%)
Jun 2008
-
$16.40M(+16.3%)
Mar 2008
-
$14.10M(-42.0%)
Dec 2007
$24.30M(-76.2%)
$24.30M(-14.1%)
Sep 2007
-
$28.30M(-18.7%)
Jun 2007
-
$34.80M(+0.3%)
Mar 2007
-
$34.70M(-65.9%)
Dec 2006
$101.90M(+47.9%)
$101.90M(+10.9%)
Sep 2006
-
$91.90M(+39.7%)
Jun 2006
-
$65.80M(+10.2%)
Mar 2006
-
$59.70M(-13.4%)
Dec 2005
$68.90M(+106.9%)
$68.90M(+6.7%)
Sep 2005
-
$64.60M(+130.7%)
Jun 2005
-
$28.00M(-38.6%)
Mar 2005
-
$45.60M(+36.9%)
Dec 2004
$33.30M(-27.8%)
$33.30M(-4.3%)
Sep 2004
-
$34.80M(-55.6%)
Jun 2004
-
$78.30M(+15.3%)
Mar 2004
-
$67.90M(+47.3%)
Dec 2003
$46.10M(+72.7%)
$46.10M(+4.5%)
Sep 2003
-
$44.10M(+53.7%)
Jun 2003
-
$28.70M(-8.3%)
Mar 2003
-
$31.30M(+17.2%)
Dec 2002
$26.70M(-37.9%)
$26.70M(-13.9%)
Sep 2002
-
$31.00M(+14.8%)
Jun 2002
-
$27.00M(+6.3%)
Mar 2002
-
$25.40M(-40.9%)
Dec 2001
$43.00M(+14.1%)
$43.00M(-2.3%)
Sep 2001
-
$44.00M(+41.5%)
Jun 2001
-
$31.10M(-52.9%)
Mar 2001
-
$66.00M(+75.1%)
Dec 2000
$37.70M(+1.3%)
$37.70M(-8.9%)
Sep 2000
-
$41.40M(-27.4%)
Jun 2000
-
$57.00M(+32.6%)
Mar 2000
-
$43.00M(+15.6%)
Dec 1999
$37.20M(+40.4%)
$37.20M(+44.2%)
Sep 1999
-
$25.80M(+61.3%)
Jun 1999
-
$16.00M(-48.9%)
Mar 1999
-
$31.30M(+18.1%)
Dec 1998
$26.50M
$26.50M(-46.6%)
Sep 1998
-
$49.60M(+18.1%)
Jun 1998
-
$42.00M(+26.1%)
Mar 1998
-
$33.30M

FAQ

  • What is Innospec annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Innospec?
  • What is Innospec annual cash & cash equivalents year-on-year change?
  • What is Innospec quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Innospec?
  • What is Innospec quarterly cash & cash equivalents year-on-year change?

What is Innospec annual cash & cash equivalents?

The current annual cash & cash equivalents of IOSP is $289.20M

What is the all time high annual cash & cash equivalents for Innospec?

Innospec all-time high annual cash & cash equivalents is $289.20M

What is Innospec annual cash & cash equivalents year-on-year change?

Over the past year, IOSP annual cash & cash equivalents has changed by +$85.50M (+41.97%)

What is Innospec quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of IOSP is $299.80M

What is the all time high quarterly cash & cash equivalents for Innospec?

Innospec all-time high quarterly cash & cash equivalents is $303.80M

What is Innospec quarterly cash & cash equivalents year-on-year change?

Over the past year, IOSP quarterly cash & cash equivalents has changed by +$29.70M (+11.00%)
On this page